Gilead to start testing inhaled version of experimental coronavirus drug remdesivir, CEO says
Remdesivir, which recently received emergency use approval to treat patients with COVID-19, will be tested in an inhaled version, biotech Gilead Sciences said on Monday.
No comments
Post a Comment